The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Chimerix
Stock and Other Ownership Interests - Chimerix
Efficacy and safety of dordaviprone (ONC201) in prospective clinical trials of adult and pediatric recurrent H3 K27M-mutant diffuse glioma patients.
 
Ashley Sumrall
Honoraria - Cardinal Health
Consulting or Advisory Role - Bayer; SERVIER
Research Funding - Chimerix (Inst); Merck (Inst); Ono Pharmaceutical (Inst)
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences
 
Joshua Allen
Employment - Chimerix; Oncoceutics
Leadership - Chimerix; Oncoceutics
Stock and Other Ownership Interests - Chimerix; Chimerix; Oncoceutics; Oncoceutics
Patents, Royalties, Other Intellectual Property - ONC201-related patents; ONC201-related patents
Travel, Accommodations, Expenses - Oncoceutics; Oncoceutics; Oncoceutics; Oncoceutics; Oncoceutics
 
Stephen Bagley
Consulting or Advisory Role - KIYATEC; Modifi Bio; SERVIER; Telix Pharmaceuticals; Third Rock Ventures
Research Funding - C2i genomics (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kite, a Gilead company; Kite, a Gilead company; Lilly (Inst); Novocure (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of intellectual property of the University of Pennsylvania licensed to Novartis: Combination Therapies of EGFRvIII Chimeric Antigen Receptors and PD-1 Inhibitors, US. Patent No. 62/809,245.
Travel, Accommodations, Expenses - Northwest Biotherapeutics
 
Thomas Brundage
Employment - Chimerix
Stock and Other Ownership Interests - Chimerix
 
Nicholas Butowski
Employment - University of California, San Francisco
Stock and Other Ownership Interests - Cordance; Cordance
Consulting or Advisory Role - IN8Bio; Ipsen; Novartis; Plus Therapeutics
Research Funding - Amgen; Amgen (Inst); Bristol-Myers Squibb (Inst); Carthera; Five Prime Therapeutics; Medicenna; Merck; Oncoceutics (Inst); Tango Therapeutics
 
Jessica Clymer
Consulting or Advisory Role - Day One Biopharmaceuticals
 
Aya Haggiagi
Research Funding - Chimerix (Inst); Pfizer (Inst)
 
Carl Koschmann
No Relationships to Disclose
 
Sylvia Kurz
No Relationships to Disclose
 
Tobey MacDonald
Consulting or Advisory Role - Day One Biopharmaceuticals
 
Nazanin Majd
Consulting or Advisory Role - Baxter (I); Celularity; Sumitomo Dainippon Pharma Co., Ltd. Consulting
Research Funding - BioMed Valley Discoveries (Inst); EMD Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst)
 
Sabine Mueller
Research Funding - BeiGene; Bristol Myers Squibb Foundation; Chimerix; Curis; Day One Biopharmaceuticals; Gilead Sciences; Kazia Therapeutics; Pfizer; Regeneron
 
Sam Ramage
Employment - Chimerix; EMD Serono; Lilly
Stock and Other Ownership Interests - Chimerix; Lilly; Merck; Merck KGaA; Pfizer
 
Rohinton Tarapore
No Relationships to Disclose
 
Reena Thomas
Research Funding - Chimerix (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending
 
Yoshie Umemura
Consulting or Advisory Role - Aptitude Health; OncLive/MJH Life Sciences; SERVIER
Speakers' Bureau - SERVIER
Research Funding - BTG (Inst); Chimerix (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst)
 
Wafik Zaky
No Relationships to Disclose
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Modifi Bio; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Cantex (Inst); CarThera (Inst); Chimerix (Inst); cns pharmaceuticals (Inst); Exelixis (Inst); MimiVax, LL (Inst); Novocure (Inst); VBI Vaccines (Inst)